AN Alzheimer’s drug which has been rejected for NHS use can slow disease progression by eight years, researchers have claimed ...

The outlook for dementia care is changing fast. UC experts explain what that means for patients and families, and what it ...

Researchers found long-term treatment could delay progression from mild cognitive impairment to moderate Alzheimer’s disease ...

Novo Nordisk A/S left open the door for additional work on its pill version of Ozempic for Alzheimer’s disease after a pair ...

GLP-1 drugs, which include Ozempic and Wegovy, have become one of the most closely watched experimental approaches for ...

Details from two large trials of Novo Nordisk's GLP-1 drug semaglutide showed it provided no cognitive benefit for people ...

Scientists have failed to show that weight-loss wonder drug semaglutide slows the progress of Alzheimer's disease (AD), as ...

As Alzheimer’s Awareness Month comes to an end, Florida State University researchers are continuing efforts to better ...

High levels of calcium are toxic to cells and contribute to loss of neurons in Alzheimer's disease. A new study published in ...

A large study found that people with impaired kidneys tend to have higher Alzheimer’s biomarkers, yet they don’t face a ...

Chris Hemsworth revealed his father's early Alzheimer's symptoms in a new documentary, 'Chris Hemsworth: A Road Trip to ...

Researchers have conducted the first study evaluating the impact of obesity on Alzheimer's disease blood biomarkers (BBMs).